Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 508

1.

Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.

Martí-Carvajal AJ, Agreda-Pérez LH, Solà I, Simancas-Racines D.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD000332. doi: 10.1002/14651858.CD000332.pub3. Review.

PMID:
23450527
2.

Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria.

Martí-Carvajal AJ, Anand V, Cardona AF, Solà I.

Cochrane Database Syst Rev. 2014 Oct 30;(10):CD010340. doi: 10.1002/14651858.CD010340.pub2. Review.

PMID:
25356860
3.

Balneotherapy (or spa therapy) for rheumatoid arthritis.

Verhagen AP, Bierma-Zeinstra SM, Boers M, Cardoso JR, Lambeck J, de Bie R, de Vet HC.

Cochrane Database Syst Rev. 2015 Apr 11;(4):CD000518. doi: 10.1002/14651858.CD000518.pub2. Review.

PMID:
25862243
4.

Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.

Palmer SC, Saglimbene V, Mavridis D, Salanti G, Craig JC, Tonelli M, Wiebe N, Strippoli GF.

Cochrane Database Syst Rev. 2014 Dec 8;(12):CD010590. doi: 10.1002/14651858.CD010590.pub2. Review.

PMID:
25486075
5.

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents.

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Cochrane Database Syst Rev. 2016 Feb 4;2:CD009624. doi: 10.1002/14651858.CD009624.pub2. Review.

PMID:
26845108
6.

Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients.

Hahn D, Cody JD, Hodson EM.

Cochrane Database Syst Rev. 2014 May 28;(5):CD003895. doi: 10.1002/14651858.CD003895.pub3. Review.

PMID:
24872328
7.

Darbepoetin for the anaemia of chronic kidney disease.

Palmer SC, Saglimbene V, Craig JC, Navaneethan SD, Strippoli GF.

Cochrane Database Syst Rev. 2014 Mar 31;(3):CD009297. doi: 10.1002/14651858.CD009297.pub2. Review.

PMID:
24683046
8.

Non-steroidal anti-inflammatory drugs for acute gout.

van Durme CM, Wechalekar MD, Buchbinder R, Schlesinger N, van der Heijde D, Landewé RB.

Cochrane Database Syst Rev. 2014 Sep 16;(9):CD010120. doi: 10.1002/14651858.CD010120.pub2. Review.

PMID:
25225849
9.

Methotrexate for treating rheumatoid arthritis.

Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD000957. doi: 10.1002/14651858.CD000957.pub2. Review.

PMID:
24916606
10.

Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.

van Herwaarden N, den Broeder AA, Jacobs W, van der Maas A, Bijlsma JW, van Vollenhoven RF, van den Bemt BJ.

Cochrane Database Syst Rev. 2014 Sep 29;(9):CD010455. doi: 10.1002/14651858.CD010455.pub2. Review.

PMID:
25264908
11.

Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.

Strippoli GF, Manno C, Schena FP, Craig JC.

Cochrane Database Syst Rev. 2003;(1):CD003967. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003967.

PMID:
12535495
12.

Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis.

Wilhelm-Leen ER, Winkelmayer WC.

Am J Kidney Dis. 2015 Jul;66(1):69-74. doi: 10.1053/j.ajkd.2014.12.012. Epub 2015 Jan 28. Review.

13.

Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.

Cody J, Daly C, Campbell M, Donaldson C, Grant A, Khan I, Pennington S, Vale L, Wallace S, MacLeod A.

Cochrane Database Syst Rev. 2001;(4):CD003266. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003266.

PMID:
11687180
14.

Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

Ohlsson A, Aher SM.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004863. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD004863.

PMID:
16856062
15.

A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.

Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C.

Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. Review.

16.

Mobile bearing vs fixed bearing prostheses for posterior cruciate retaining total knee arthroplasty for postoperative functional status in patients with osteoarthritis and rheumatoid arthritis.

Hofstede SN, Nouta KA, Jacobs W, van Hooff ML, Wymenga AB, Pijls BG, Nelissen RG, Marang-van de Mheen PJ.

Cochrane Database Syst Rev. 2015 Feb 4;(2):CD003130. doi: 10.1002/14651858.CD003130.pub3. Review.

PMID:
25650566
17.

Growth factors for treating diabetic foot ulcers.

Martí-Carvajal AJ, Gluud C, Nicola S, Simancas-Racines D, Reveiz L, Oliva P, Cedeño-Taborda J.

Cochrane Database Syst Rev. 2015 Oct 28;(10):CD008548. doi: 10.1002/14651858.CD008548.pub2. Review.

PMID:
26509249
18.

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.

Ruiz Garcia V, Jobanputra P, Burls A, Cabello JB, Vela Casasempere P, Bort-Marti S, Kynaston-Pearson FJ.

Cochrane Database Syst Rev. 2014 Sep 18;(9):CD007649. doi: 10.1002/14651858.CD007649.pub3. Review.

PMID:
25231904
19.

Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.

Cody J, Daly C, Campbell M, Donaldson C, Grant A, Khan I, Vale L, Wallace S, MacLeod A.

Cochrane Database Syst Rev. 2002;(4):CD003895. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003895.

PMID:
12519614
20.

Early versus delayed erythropoietin for the anaemia of end-stage kidney disease.

Coronado Daza J, Martí-Carvajal AJ, Ariza García A, Rodelo Ceballos J, Yomayusa González N, Páez-Canro C, Loza Munárriz C, Urrútia G.

Cochrane Database Syst Rev. 2015 Dec 16;(12):CD011122. doi: 10.1002/14651858.CD011122.pub2. Review.

PMID:
26671531

Supplemental Content

Support Center